Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-05 Purchase |
2021-02-09 7:56 pm |
Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner |
250,187 | $12.84 | $3,212,446 | 14,869,915 (Indirect) |
View |
| 2021-02-08 Purchase |
2021-02-08 6:08 pm |
Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner |
1,250,000 | $16 | $20,000,000 | 14,619,728 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 5:27 pm |
2023-06-23 2032-06-23 |
LianBio | LIAN | Poukalov Konstantin Director |
36,300 | $0 | 17,082 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-20 5:27 pm |
N/A N/A |
LianBio | LIAN | Poukalov Konstantin Director |
19,218 | $4.76 | 17,082 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 5:27 pm |
N/A N/A |
LianBio | LIAN | Poukalov Konstantin Director |
36,300 | $2.52 | 17,082 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:50 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:10 pm |
N/A 2033-06-21 |
LianBio | LIAN | Poukalov Konstantin Director |
36,300 | $0 | 36,300 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 5:37 pm |
N/A 2032-06-23 |
LianBio | LIAN | Poukalov Konstantin Director |
36,300 | $0 | 36,300 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
7,250 | $0 | 7,250 (Direct) |
View |
Ownership |
2021-10-29 6:36 pm |
N/A 2030-12-17 |
LianBio | LIAN | Poukalov Konstantin Director |
0 | $0 | 146,195 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:25 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-02-08 Conversion |
2021-02-08 6:08 pm |
N/A N/A |
Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner |
26,739,456 | $0 | 14,619,728 (Indirect) |
View |
Ownership |
2021-02-03 6:29 pm |
N/A N/A |
Landos Biopharma Inc. | LABP | Poukalov Konstantin Director 10% Owner |
0 | $0 | 13,369,728 (Indirect) |
View |
| 2020-04-30 Option Award |
2020-05-01 6:38 pm |
N/A 2030-04-29 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
14,500 | $0 | 14,500 (Direct) |
View |